Livforsakringsbolaget Skandia Omsesidigt Purchases 71,000 Shares of Cardinal Health, Inc. (NYSE:CAH)

Livforsakringsbolaget Skandia Omsesidigt boosted its holdings in shares of Cardinal Health, Inc. (NYSE:CAH - Free Report) by 1,224.3% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 76,799 shares of the company's stock after buying an additional 71,000 shares during the period. Livforsakringsbolaget Skandia Omsesidigt's holdings in Cardinal Health were worth $9,083,000 as of its most recent filing with the Securities and Exchange Commission.

Other large investors have also recently bought and sold shares of the company. Paragon Capital Management Inc. increased its holdings in shares of Cardinal Health by 0.7% in the 3rd quarter. Paragon Capital Management Inc. now owns 14,857 shares of the company's stock valued at $1,642,000 after purchasing an additional 99 shares during the period. Huntington National Bank increased its stake in Cardinal Health by 0.9% in the 3rd quarter. Huntington National Bank now owns 10,792 shares of the company's stock valued at $1,193,000 after buying an additional 100 shares during the period. Frazier Financial Advisors LLC lifted its position in Cardinal Health by 69.8% in the 3rd quarter. Frazier Financial Advisors LLC now owns 253 shares of the company's stock worth $28,000 after buying an additional 104 shares in the last quarter. UMB Bank n.a. boosted its stake in shares of Cardinal Health by 4.9% during the 3rd quarter. UMB Bank n.a. now owns 2,249 shares of the company's stock valued at $249,000 after buying an additional 106 shares during the period. Finally, Raleigh Capital Management Inc. grew its holdings in shares of Cardinal Health by 29.6% during the 4th quarter. Raleigh Capital Management Inc. now owns 464 shares of the company's stock valued at $55,000 after acquiring an additional 106 shares in the last quarter. 87.17% of the stock is owned by institutional investors and hedge funds.

Cardinal Health Stock Up 0.9 %

CAH stock traded up $1.18 during mid-day trading on Tuesday, reaching $128.38. 2,357,216 shares of the stock traded hands, compared to its average volume of 2,377,882. The business has a 50-day moving average of $122.66 and a two-hundred day moving average of $115.83. The firm has a market capitalization of $31.01 billion, a PE ratio of 23.95, a P/E/G ratio of 1.49 and a beta of 0.63. Cardinal Health, Inc. has a 52 week low of $93.17 and a 52 week high of $132.84.

Cardinal Health (NYSE:CAH - Get Free Report) last released its earnings results on Thursday, January 30th. The company reported $1.93 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.74 by $0.19. Cardinal Health had a negative return on equity of 59.57% and a net margin of 0.59%. On average, equities research analysts anticipate that Cardinal Health, Inc. will post 7.95 EPS for the current fiscal year.

Cardinal Health Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Tuesday, April 15th. Investors of record on Tuesday, April 1st will be given a dividend of $0.5056 per share. This represents a $2.02 dividend on an annualized basis and a yield of 1.58%. The ex-dividend date of this dividend is Tuesday, April 1st. Cardinal Health's dividend payout ratio (DPR) is currently 37.69%.

Wall Street Analyst Weigh In

Several analysts recently issued reports on the company. Wells Fargo & Company increased their price objective on Cardinal Health from $135.00 to $136.00 and gave the stock an "equal weight" rating in a report on Tuesday, February 4th. Jefferies Financial Group raised Cardinal Health from a "hold" rating to a "buy" rating and raised their price target for the stock from $140.00 to $150.00 in a research note on Wednesday, February 5th. Mizuho started coverage on Cardinal Health in a research note on Wednesday, December 4th. They issued an "outperform" rating and a $139.00 price target for the company. TD Cowen raised shares of Cardinal Health from a "hold" rating to a "buy" rating and raised their price objective for the company from $130.00 to $144.00 in a research report on Wednesday, January 8th. Finally, Deutsche Bank Aktiengesellschaft boosted their target price on shares of Cardinal Health from $119.00 to $124.00 and gave the stock a "hold" rating in a research report on Monday, November 4th. Four investment analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the stock. Based on data from MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and a consensus price target of $136.87.

Cardinal Health Company Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.